Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome
NCT02252406
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Stable Angina
Metabolic Syndrome
Interventions
DRUG:
Ranolazine
OTHER:
Placebo
Sponsor
University of Florida